BRPI0512503A - composição que compreende ácido lático e lactoferrina - Google Patents

composição que compreende ácido lático e lactoferrina

Info

Publication number
BRPI0512503A
BRPI0512503A BRPI0512503-0A BRPI0512503A BRPI0512503A BR PI0512503 A BRPI0512503 A BR PI0512503A BR PI0512503 A BRPI0512503 A BR PI0512503A BR PI0512503 A BRPI0512503 A BR PI0512503A
Authority
BR
Brazil
Prior art keywords
composition
lactoferrin
lactic acid
treatment
prophylaxis
Prior art date
Application number
BRPI0512503-0A
Other languages
English (en)
Inventor
Bjoern Andersch
Inger Mattsby-Baltzer
Original Assignee
Nestor Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestor Medical Ab filed Critical Nestor Medical Ab
Publication of BRPI0512503A publication Critical patent/BRPI0512503A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

COMPOSIçãO QUE COMPREENDE áCIDO LáTICO E LACTOFERRINA A presente invenção refere-se a uma composição que compreende ácido lático e lactoferrina e/ou um fragmento peptídico da mesma, para o tratamento e/ou profilaxia de condições no trato urogenital. Descreve-se também o uso de tal composição para a preparação de um medicamento para o tratamento e/ou profilaxia de condições no trato urogenital, bem como um método para o tratamento das mesmas.
BRPI0512503-0A 2004-06-23 2005-06-23 composição que compreende ácido lático e lactoferrina BRPI0512503A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401631A SE528337C2 (sv) 2004-06-23 2004-06-23 Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
PCT/SE2005/000989 WO2006001766A1 (en) 2004-06-23 2005-06-23 Composition comprising lactic acid and lactoferrin

Publications (1)

Publication Number Publication Date
BRPI0512503A true BRPI0512503A (pt) 2008-03-11

Family

ID=32768753

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512503-0A BRPI0512503A (pt) 2004-06-23 2005-06-23 composição que compreende ácido lático e lactoferrina

Country Status (15)

Country Link
US (1) US20080161234A1 (pt)
EP (1) EP1784176B1 (pt)
JP (1) JP2008503576A (pt)
KR (1) KR20070048170A (pt)
CN (1) CN1972683A (pt)
AT (1) ATE464045T1 (pt)
AU (1) AU2005257722B2 (pt)
BR (1) BRPI0512503A (pt)
CA (1) CA2571183A1 (pt)
DE (1) DE602005020639D1 (pt)
NZ (1) NZ552764A (pt)
RU (1) RU2398575C2 (pt)
SE (1) SE528337C2 (pt)
WO (1) WO2006001766A1 (pt)
ZA (1) ZA200703166B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100801891B1 (ko) * 2006-11-02 2008-02-12 한상진 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
JP5409596B2 (ja) * 2007-03-30 2014-02-05 ラキュアー エービー 婦人科の障害の治療における乳酸オリゴマーの使用
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid
AU2010206221B2 (en) 2009-01-23 2016-07-14 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Controlled release pharmaceutical or food formulation and process for its preparation
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
WO2014012805A1 (en) * 2012-07-16 2014-01-23 Laccure Ab Pharmaceutical compositions containing oligomeric lactic acid
ITMI20122152A1 (it) * 2012-12-17 2014-06-18 Progine Farmaceutici S R L Composizione per uso topico.
EP2992894A1 (en) * 2014-09-05 2016-03-09 Progine Farmaceutici Srl Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections
RU2637649C2 (ru) * 2014-10-30 2017-12-05 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ) Способ и реагент-индикатор для рН-метрии вагинальной жидкости
MX2017016991A (es) * 2017-12-20 2019-06-21 Centro De Retina Medica Y Quirurgica S C Formulación para la administración oral de extracto de arándano azul como auxiliar en la conservación de la salud de la película lagrimal en seres humanos.
EP4260869A1 (en) * 2022-04-11 2023-10-18 Reckitt Benckiser Health Limited Composition comprising a combination of lactoferrin and a sulphated polysaccharide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
US5656591A (en) * 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP2001504447A (ja) * 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
US6240320B1 (en) * 1998-06-05 2001-05-29 Intermedics Inc. Cardiac lead with zone insulated electrodes
AU4059999A (en) * 1998-06-05 1999-12-30 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
JP3439686B2 (ja) * 1999-03-30 2003-08-25 雪印乳業株式会社 鉄強化飲料
IT1317937B1 (it) * 2000-11-17 2003-07-15 Sigma Tau Healthscience Spa Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

Also Published As

Publication number Publication date
CN1972683A (zh) 2007-05-30
CA2571183A1 (en) 2006-01-05
ZA200703166B (en) 2008-08-27
AU2005257722A1 (en) 2006-01-05
JP2008503576A (ja) 2008-02-07
NZ552764A (en) 2010-03-26
SE528337C2 (sv) 2006-10-24
SE0401631L (sv) 2005-12-24
RU2398575C2 (ru) 2010-09-10
SE0401631D0 (sv) 2004-06-23
ATE464045T1 (de) 2010-04-15
KR20070048170A (ko) 2007-05-08
WO2006001766A1 (en) 2006-01-05
RU2007102273A (ru) 2008-07-27
DE602005020639D1 (de) 2010-05-27
AU2005257722B2 (en) 2009-03-12
US20080161234A1 (en) 2008-07-03
EP1784176A1 (en) 2007-05-16
EP1784176B1 (en) 2010-04-14

Similar Documents

Publication Publication Date Title
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
MX341883B (es) Composicion farmaceutica para el tratamiento y prevencion de canceres.
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
NZ594814A (en) Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
TW201129378A (en) Materials and methods for treating or preventing HER-3 associated diseases
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
BRPI0921999B8 (pt) uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
WO2007095288A3 (en) Methionine-containing protein or peptide compositions and methods of making and using
BRPI0511367A (pt) uso de uma composição,composição, uso de vip e/ou de um fragmento ativo do mesmo
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
WO2006135493A3 (en) A composition for wound healing and use thereof
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
NO20076405L (no) Anvendelse av 24-nor-UDCA
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
ATE455789T1 (de) Substituierte nonadepsipeptide
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
EP1804789A4 (en) METHOD FOR TREATING PREECLAMPSY IN HUMANS WITH RESIBUFAGENIN
WO2005077046A3 (en) A composition and method of treating mastitis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2158 DE 15/05/2012.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2164 DE 26/06/2012.